Navigation Links
Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
Date:5/26/2009

ne signature biomarker development. Abstract #3577; Poster Board #J19; Developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m.

Min P, et al. Small molecule pan-bcl-2 inhibitor AT-101 induces apoptosis in NSCLC by upregulating noxa and enhances antitumor activity of docetaxel or targeted kinase inhibitors. Abstract #e14591; Publication only.

Non-Hodgkin's Lymphoma

Kingsley E, et al. An open-label, multicenter, phase II study of AT-101 in combination with rituximab (R) in patients with untreated, grade I-II, follicular Non-Hodgkin's Lymphoma (FL). Abstract #8582; Poster Board #S11; Lymphoma and Plasma Cell Disorders, May 30, 8:00 a.m.-12:00 p.m.

Advanced Cancers

Leal TB, et al. A phase I study of AT-101 in combination with cisplatin (P) and etoposide (E) in patients with advanced solid tumors and extensive-stage small cell lung cancer (ES-SCLC). Abstract #e13502; Publication only.

Saleh M, et al. Extended phase I trial of the oral pan-Bcl-2 inhibitor AT-101 by multiple dosing schedules in patients with advanced cancers. Abstract #e14537; Publication only.

Mechanism of Action/Pharmacokinetics

Wang S, et al. AT-101 induces transcriptional up-regulation of Noxa and Puma and overcomes Mcl-1-mediated cancer cell resistance to apoptosis. Abstract # e14611; Publication only.

Pitot H, et al. Analysis of a phase I pharmacokinetic (PK)/food effect study of AT-101 in patients with advanced solid tumors. Abstract #2557; Poster Board #B18; Developmental Therapeutics, May 30, 8:00 a.m.-12:00 p.m.

About AT-101

AT-101 is an orally-active, pan-Bcl-2 inhibitor (including Bcl-2, Bcl-xL, Bcl-w, and Mcl-1 inhibition) that has been shown to induce apoptosis directly by operating as a BH3 mimetic and indirectly as an independent upregulator of Noxa and Puma. By blocking the binding of Bcl-2 family me
'/>"/>

SOURCE Ascenta Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
2. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
3. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
4. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
5. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
8. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
9. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
10. Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Pa. , June 2, 2015 Today ...  build three new distribution centers in Olive ... ; and Newburgh, NY . The ... company,s ability to improve product access, increase supply chain ... announcement is part of the company,s ongoing investments, more ...
(Date:6/2/2015)... Calif. , June 2, 2015  Accuray Incorporated ... team is scheduled to present at the Goldman Sachs ... Palos Verdes, California on Wednesday, June 10, ... webcast of the presentation will be available on the ... http://www.accuray.com/investors .  The webcast replay of the presentation will ...
(Date:6/2/2015)... BOSTON , June 2, 2015  Ovatemp proudly ... their fertility throughout their entire reproductive life cycle, from ... with the ONDO Bluetooth basal thermometer and connected Ovatemp ... odds of getting pregnant, or avoid pregnancy altogether. The ... and the free Ovatemp app can be downloaded from ...
Breaking Medicine Technology:AmerisourceBergen to Build Three New Distribution Centers 2Techstars-backed Startup Ovatemp Launches the Only Complete, Personalized Fertility Management Platform for Women 2
... Data from experimental work on the use,of ... this week at the,International Society for Heart and ... donors after cardiac death,(DCD), also known as non-heart-beating ... shortage of suitable donor organs for lung, and,possibly ...
... Institute,s NABTT ... Consortium -, ... expansion of the clinical program for the company,s lead,product candidate, BSI-201, ... first poly ADP-ribose polymerase,(PARP) inhibitor in BiPar,s DNA repair portfolio, crosses ...
Cached Medicine Technology:Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 2Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
(Date:6/2/2015)... DuPont Pioneer , one of the world’s ... and office facility in Zambia that will increase maize ... and export markets to Kenya, Tanzania and other markets ... breadbasket for southern Africa provided an enabling agricultural environment ... Africa senior business manager of DuPont Pioneer “Our aim ...
(Date:6/2/2015)... 02, 2015 ODU , ... performance connector solutions and cable assemblies, is announcing ... to the US market. , ODU MINI-SNAP® ... capabilities. The self- securing circular connector solution is ... that require significant customization such as: sensor devices, ...
(Date:6/2/2015)... PhishLine, LLC today announced it ... Drive, Suite 125 in Waukesha, Wisconsin 53186. ... base of operations for PhishLine’s current corporate staff ... , Mark Chapman, Founder and President, commented “PhishLine ... enterprise customers adopt our market leading service to ...
(Date:6/2/2015)... 02, 2015 The Non-GMO Project ... products made according to rigorous best practices for ... produced in compliance with the Non-GMO Project Standard ... risk ingredients, facility inspections and an annual audit ... avoidance. , “Savoury Systems is and has always ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 TheCelebrityDresses.com, a ... announced big discounts on their summer fashion cocktail dresses. ... and short dresses that would be suitable for a ... parties. , TheCelebrityDresses.com designs and make high quality ... fabrics they use include high quality satin, chiffon and ...
Breaking Medicine News(10 mins):Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 2Health News:Investing in Infrastructure Critical to Advancing Food Security in Zambia 3Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:PhishLine, LLC Announces New Corporate Headquarters 2Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2
... in preventing colorectal tumors in two mouse models of the ... The findings are published in the November issue of ... third most common cancer and the second leading cause of ... according to the National Cancer Institute. Building on previous ...
... 2 (HealthDay News) -- A patient-tailored fall prevention program ... patients, a new study reports. Hospital patients are ... and being in an unfamiliar environment. Falls and fall-related ... care workers and the health care system, according to ...
... -- A certain area of the cerebral cortex is thinner ... a new study. The cerebral cortex is an area ... impulse control and decision making. German researchers obtained high-resolution ... 21 people who never smoked. Using these images, the scientists ...
... a condition that may be responsible for up to ... to one-fifth of all cases of blood clots in ... few randomized clinical trials have been conducted involving people ... of participants. To stimulate an international discussion on ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Certain ... people with chronic obstructive pulmonary disorder (COPD), which includes ... For the study, 20 COPD patients (13 women, seven ... of vitamins A, C, D, E and selenium, all ...
... , TUESDAY, Nov. 2 (HealthDay News) -- Extroverts are ... had lots of social activity than after they,ve been alone, ... (outgoing, unreserved folks) and 25 introverts (reserved, shy types), aged ... "socially enriched group" or a "socially impoverished group." Those ...
Cached Medicine News:Health News:Black raspberries may prevent colon cancer, study finds 2Health News:Program May Help Prevent Falls in Hospitalized Patients 2Health News:International summit held to stimulate collaborative clinical research on antiphospholipid syndrome 2Health News:Poor Diet May Make COPD Worse, Study Finds 2Health News:Socializing Tied to Sleep Deprivation in Extroverts 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: